1st Biotherapeutics Company
1STBIO is dedicated to developing breakthrough therapies with a key value to provide novel medicines to patients.
Total Funding:
14289918
Last Funding Type:
Series B
Investors Number:
4
Industry:
Neurodegeneration and Aging
Founded Date:
2016-01-01
Last Funding Date:
2020-07-30
Employee Number:
1-10
Headquarters:
Seongnam, Kyonggi-do, South Korea
Funding Status:
Early Stage Venture